Tourism suffers again on the stock market due to delays in vaccines against the coronavirus
How do pandemics end? History suggests diseases fade but are almost never truly gone
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDA
J&J Offers Up To $5B In US Opioid Addiction Settlement
Moderna Kicks Off Rolling Submission Of Covid-19 Vaccine In Canada
Buy the rumour, sell the fact
Tactical Update: Uncertainty Abounds
Eli Lilly pauses trial of Covid-19 antibody drug over safety concern
Euro Falls Against Dollar on Risk-Off Sentiment As Investors Flee
Political leaders’ views on COVID-19 risk are highly infectious in a polarized nation – we see the same with climate change
US Close – Reality Check Tuesday, Apple delivers, Earnings, Vaccine and antibody doubts, Stimulus, Big-Tech Events, Oil rises, Gold slumps
Wall Street October Survey: Most Expect A Contested Election, February Vaccine And W-Shaped Recovery
Peter Schiff: The Best Of Times During The Worst Of Times
USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19
Facebook Bans Ads Questioning Safety Of COVID-19 Vaccines
J&J pauses Covid-19 vaccine trials
Oil enjoying reprieve, gold coming under pressure
Trump: "I Was Right About Damaging Lockdowns"
Political leaders' attitudes toward COVID-19 risk are highly infectious in a polarized nation – just like climate change denial
Nasdaq Futures Surge Despite Vaccine Setback As Gamma Squeeze Continues
Itamar Medical To Outperform 3Q Sales Est., Reinstates 2020 Guidance
US Open – Big tech buzzing once again
Existing medicines could help improve immune function in vulnerable older adults
Exelon Jumps On Possible Non-Utility Divestment; Analyst Sees 50% Upside
Dynavax Surges 7% In Pre-Market On Taiwan Covid-19 Vaccine Subsidy
Pfizer, BioNTech Ink Deal To Supply 1.5M Covid Vaccines To New Zealand
Can we actually learn to live with coronavirus? Not until we have a vaccine
Nestlé Completes Tender Offer For 84% Stake In Aimmune Therapeutics
Macro Briefing: 13 October 2020
Altimmune's COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside